MADRID Dec 15 Spain's Grifols, which
on Wednesday said it would buy U.S. Hologic Inc's
assets in their blood screening joint venture, will refinance
its net debt in the first quarter of next year, its Chief
Financing Officer said on Thursday.
"Assuming the market is okay ... we're convinced that we
could go to the market and refinance our debt in the first
quarter," Grifol's Chief Financing Officer Alfredo Arroyo told
Reuters on Thursday.
The company, which develops plasma protein therapies, aims
to return its debt/core profit ratio to 3 times within a couple
of years compared to 4.3 times in pro-forma terms, including a
$1.7 billion loan also announced on Wednesday.
(Reporting by Emma Pinedo; Writing by Paul Day)